Skip to main content
Clinical Trials/CTRI/2021/12/038511
CTRI/2021/12/038511
Completed
Phase 1

Effect of Myofascial release on pain and health-related quality of life in females with abnormal uterine bleeding: A two group pre-test post-test study design

MMD0 sites27 target enrollmentTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
MMD
Enrollment
27
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
February 26, 2022
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
MMD

Eligibility Criteria

Inclusion Criteria

  • Women in reproductive age group 18\-40years.
  • Body Mass Index (normal18\.5\-24\.9, over weight 25\.0\-29\.9 kg/m2\)
  • Chronic AUB having any of these menstrual cycle \>34 days or \<24 days, duration of flow \>8 days \<4 day, heavy bleed during cycle, primary
  • dysmenorrhea, oligomenorrhea
  • Pain as measured on VAS equal to or more than 5 at base line.

Exclusion Criteria

  • Pregnant females, obese females, recent incontinence surgery , neurogenic bladder, diabetic nephropathy, patient with positive urine culture, patients with painful abdominal scarsAbdominal pain due to other reasons in the last 6 months.Other pelvic disorders like PCOD/PCOS
  • Cardiac pacemakers, History of Tuberculosis, Thyroid disorders, Psychological distress in the last 6 months.

Outcomes

Primary Outcomes

Not specified

Similar Trials